[ParlTrack]

Motion for a resolution
Recital L a (new)

La. whereas the NHCR states that “probiotics/prebiotics” should be considered a health claim, currently either unauthorised or “on-hold” claims1a, for the exception of the lactose digestion of traditional yoghurt cultures which reduces lactose intolerance1b; whereas the labelling is employed with Latin terms for a particular strain of bacteria, which is not easily understood and creates confusion rather than clarity among consumers; _________________ 1a Farnworth Edward R. (2008) The Evidence to Support Health Claims for Probiotics. The Journal of Nutrition, Volume 138, Issue 6, Pages 1250S-1254S 1b Facioni, M. S., Raspini, B., Pivari, F., Dogliotti, E., & Cena, H. (2020). Nutritional management of lactose intolerance: the importance of diet and food labelling. Journal of translational medicine, 18(1), 260. https://doi.org/10.1186/s12967-020- 02429-2

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Recital L b (new)

Lb. whereas digestive health issues linked with the gut microbiome dysregulation present a clear association with mental health conditions, cardiovascular diseases, allergies, and other inflammatory autoimmune disorders1a; _________________ 1a Vijay, A., Valdes, A.M. Role of the gut microbiome in chronic diseases: a narrative review. Eur J Clin Nutr 76, 489–501 (2022). https://doi.org/10.1038/s41430-021- 00991-6

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Recital L c (new)

Lc. whereas Europeans are the worst affected by inflammatory bowel disease: about 10 in 100.000 people suffer from ulcerative colitis and about 5 in 100.000 people from Crohn's disease alone1a; whereas inflammatory bowel disease is the first cause of disease burden among digestive diseases in Europe1b, with increasing prevalence1c; _________________ 1a CORDIS - EU Research results (2017), Systems medicine of chronic inflammatory bowel disease (SysmedIBD) - The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 305564. 1b Wang, R., Li, Z., Liu, S.; Zhang, D. (2023). Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.10614 53 1c Alatab, S. et al. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. The Lancet Gastroenterology & Hepatology, 5(1), 17–30. https://doi.org/10.1016/s2468- 1253(19)30333-4

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Recital L d (new)

Ld. whereas current clinical guidelines state that the use of probiotics are effective and safe for some medical conditions, including mild to moderately active ulcerative colitis in pediatric and adult populations 1a,1b; whereas “probiotics” present potential protective use in respiratory, diarrhoeal and other infections1c; _________________ 1a World Gastroenterology Organisation Global Guidelines (2023) Probiotics and prebiotics 1b Bischoff et al. (2023) ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clinical Nutrition, Volume 42, Issue 3, P352-379 1c Li X, Wang Q, Hu X, Liu W. (2022) Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases. Front Cell Infect Microbiol. 14;12:789063. https://doi.org/10.3389/fcimb.2022.789063

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Recital L e (new)

Le. whereas consumption of probiotics and prebiotics have increased in the last few years1a; whereas 79% of people want to be educated about digestive health, including probiotics and food supplements1b; _________________ 1a Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020). Update of Probiotics in Human World: A Nonstop Source of Benefactions till the End of Time. Microorganisms, 8(12), 1907. https://doi.org/10.3390/microorganisms81 21907 1b Food Supplements Europe (2021) Probiotics: growing science and need for proper consumer communication on probiotic food supplements

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Paragraph 7 a (new)

7a. Brings the attention to the influence of social determinants in consumer’s literacy of nutrition claims; stresses the need for adopting of a harmonised, mandatory, and effective front-of-pack nutrition labelling system which summarises nutritional profiles of different food products, and respective monitoring mechanisms;

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Subheading 4 a (new)

Prebiotics and Probiotics

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Paragraph 13 a (new)

13a. Highlights the different interpretations of NHCR in regards to prebiotics and probiotics by Member States, reflected by the adoption of national guidelines and rules that allow the use of probiotics in several EU countries, which creates confusion for consumers, uncertainty for companies and fragmentation and unfairness of the single market;

2023/10/16
Committee: ENVI

Sara CERDAS

Motion for a resolution
Paragraph 13 b (new)

13b. Acknowledges the incoherence between legislation and clinical recommendations for pre- and probiotics; highlights the need to strengthen the scientific evidence of health claims for ‘probiotics’ and ‘prebiotics; calls for the harmonisation of the authorised “probiotics” in food and food supplements across Member States;

2023/10/16
Committee: ENVI

9 Amendments of Sara CERDAS related to 2023/2081(INI)

ParlTrack - 2011-2024